Keynote Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Keynote Financial Services’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.93M	Buy	33,564 +1,539	+5%	+$88.4K	0.91%	29
2026 Q1	$1.94M	Sell	32,025 -267	-0.8%	-$15.6K	1.03%	20
2025 Q4	$1.74M	Buy	32,292 +130	+0.4%	+$6.25K	0.97%	26
2025 Q3	$1.45M	Buy	32,162 +43	+0.1%	+$2.01K	0.87%	31
2025 Q2	$1.49M	Buy	32,119 +293	+0.9%	+$14.4K	1%	27
2025 Q1	$1.94M	Buy	31,826 +467	+1%	+$27.2K	1.39%	16
2024 Q4	$1.77M	Buy	31,359 +119	+0.4%	+$6.65K	1.36%	15
2024 Q3	$1.62M	Buy	31,240 +535	+2%	+$25.1K	1.23%	19
2024 Q2	$1.28M	Buy	30,705 +2,955	+11%	+$132K	1.07%	27
2024 Q1	$1.5M	Buy	+27,750	New	+$1.41M	1.26%	21

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Keynote Financial Services's BMY Position: Q2 2026 in Review

Keynote Financial Services increased its Bristol-Myers Squibb (BMY) stake by 4.8% in Q2 2026, buying an estimated $88.4K and bringing the position to 33,564 shares worth $1.93M. The position accounts for 0.91% of the portfolio, ranked #29.

Keynote Financial Services first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.94M in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Keynote Financial Services held 33,564 shares of Bristol-Myers Squibb worth $1.93M as of Q2 2026.
Keynote Financial Services bought 1,539 Bristol-Myers Squibb shares in Q2 2026, an estimated $88.4K.
Bristol-Myers Squibb made up 0.91% of Keynote Financial Services's portfolio in Q2 2026, its #29 holding.
Keynote Financial Services first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
Keynote Financial Services's Bristol-Myers Squibb position peaked at $1.94M in Q1 2026.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.